India and the European Union will commence their tenth round of negotiations for a proposed free trade agreement in Brussels.

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and targeted oncology company, for $355 million. The deal is in line with Sun ...

Scam center survivors have found themselves trapped once again, this time in overcrowded facilities with no medical care, ...

The upfront cash payment of $4.10 per share of common stock represents a premium of around 66% to Checkpoint’s closing share ...

French President Emmanuel Macron is back at the centre of global diplomacy, seeking to ease relations with President Donald Trump, championing a Ukraine peace plan alongside his British counterpart, ...

Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.